To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Genencor Licenses the ERGO™ Genomics Platform from Integrated Genomics
Integrated Genomics announced that Genencor the biotechnology division of Danisco A/S that develops enzymes and bio-products, has licensed the ERGO™ bioinformatics software system to characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles, oil and chemical industries.
ERGO™ is a powerful software platform for analyzing genome sequences and performing gene annotations, metabolic reconstructions, and other gene analyses and comparisons.
Optimized for analysis of microorganisms, ERGO™ integrates biological data from genomics, biochemistry, gene expression studies, genetics and literature.
Reaching beyond conventional systems for functional analysis of DNA sequences, Integrated Genomics' platform combines pattern-based analysis with comparative genomics and enables visualization of genes in the contexts of regulation, gene expression data, phylogeny, chromosomal neighborhoods and identification of natural gene fusions.
ERGO™ contains more than 1145 genomes at various stages of completion, as well as the largest available collection of networked cellular pathways.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
